Attendee search 

APL is a full scale Contract Development and Manufacturing Organisation. Modern manufacturing processes and staff with cutting edge competence make APL a competent partner and supplier. We develop and manufacture pharmaceuticals and consumables for companies throughout the world. Our offers extend from the early research phase to commercial product.

 

NovaHep was founded in 2005 on the basis of research conducted at the Huddinge unit of the Karolinska Institute in Stockholm. The company is now based in Gothenburg, Sweden, at the Biotech Center.
NovaHep is active within the field of regenerative medicine, developing stem cell technology with a wide range of applications.
The main area of focus is the production of biological, individualised vessels, in collaboration with the University of Gothenburg. The vessels can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The product is unique and patented. Through an improved alternative to traditional treatments, NovaHep will deliver a life changing impact to patients and provide for major benefits for hospitals, healthcare providers and society – globally.
NovaHep also works with liver stem cells for the purpose of developing a system in which drugs can be tested without the use of laboratory animals.